Aplastic anemia is a hematologic condition occasionally presenting during pregnancy. This
pathological process is associated with significant maternal and neonatal morbidity and …

Hematologic complications are common in pregnancy and can significantly impact both
maternal and fetal health. Recognizing and treating these complications can be challenging …

Objective: To analyze obstetric complications associated with aplastic anemia (AA) among
pregnant women and analyze the underlying factors. Methods: A retrospective analysis of 60 …

Introduction Aplastic anemia is a rare disease caused by destruction of pluripotent stem cells
in bone marrow. During pregnancy it could be life-threatening for both mother and child. The …

Objective Immunosuppressant therapy (IST) with antithymocyte globulin (ATG) and
cyclosporine is an established treatment option for patients with aplastic anemia (AA), who …

Introduction: Pregnancy-associated aplastic anemia (pAA) occurs when aplastic anemia
(AA) is diagnosed for the first time during pregnancy and it is a rare but serious condition …

妊娠合并再生障碍性贫血是妊娠期一种严重的并发症, 以贫血, 出血及感染为主,
病因包括药物因素, 化学因素, 感染和放射线照射等. 治疗以对症支持治疗为主 …

Aplastic anaemia in pregnancy is a serious condition for both the mother and child. In the
20th century, maternal morbidity was reported to be 20-60% and termination of pregnancy at …